Resmed (RMD) Amortization of Deferred Charges (2021 - 2026)

Resmed (RMD) has 6 years of Amortization of Deferred Charges data on file, last reported at $10.1 million in Q1 2026.

• Quarterly Amortization of Deferred Charges rose 22.05% year-over-year to $10.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.1 million (up 14.23% YoY) and the FY2025 annual result came in at $37.3 million, down 5.09% from the prior year.
• Amortization of Deferred Charges slipped to $10.1 million in Q1 2026, from $12.4 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $12.4 million in Q4 2025 to a low of $7.6 million in Q2 2022.
• A 5-year average of $9.3 million and a median of $9.0 million in 2024 frame the typical range for Amortization of Deferred Charges.
• Annual changes were most pronounced in 2024 — Amortization of Deferred Charges jumped 32.42% — and 2025, when it declined 26.26%.
• Tracing RMD's Amortization of Deferred Charges over 5 years: stood at $7.8 million in 2022, then grew by 10.47% to $8.6 million in 2023, then gained by 10.21% to $9.5 million in 2024, then jumped by 31.51% to $12.4 million in 2025, then fell by 19.24% to $10.1 million in 2026.
• The last three Amortization of Deferred Charges figures came in at $10.1 million (Q1 2026), $12.4 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.